Semin Thromb Hemost 2009; 35(1): 050-059
DOI: 10.1055/s-0029-1214148
© Thieme Medical Publishers

The Role of D-dimer Testing in Patients with Suspected Venous Thromboembolism

Domenico Prisco1 , Elisa Grifoni1
  • 1Department of Medical and Surgical Critical Care, University of Florence; and Department of Heart and Vessels, Thrombosis Centre, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy
Weitere Informationen

Publikationsverlauf

Publikationsdatum:
23. März 2009 (online)

Zoom Image

ABSTRACT

D-dimer, the final degradation product of cross-linked fibrin, is typically elevated in patients with acute venous thromboembolism. With its high sensitivity and negative predictive value, D-dimer testing may have a role for ruling-out the diagnosis in patients with suspected deep vein thrombosis or pulmonary embolism. For this purpose, D-dimer testing has been integrated in sequential diagnostic strategies including those using pretest clinical probability assessment and imaging techniques. A large variety of assays are now available for D-dimer measurement, with different sensitivities and specificities for the diagnosis of venous thromboembolism. Attempts to standardize the various D-dimer assays have been made but without any definitive answers as yet. The diagnostic yield of D-dimer testing is affected not only by the choice of the appropriate assay but also by patient characteristics. As a consequence, the clinical usefulness of D-dimer testing for the exclusion of suspected venous thromboembolism should be carefully evaluated in special clinical settings.